TreatOnce™ is a clinical decision support software that maps targeted antimicrobial treatment options based on detected pathogens and antimicrobial resistance genes. Laboratories enter this data into the software application, which produces a structured, printable report that summarizes pathogen-specific treatment options. The system accounts for drug allergies into the treatment mapping process. This report includes pathogens, resistance markers, and recommended first-line and alternate antimicrobial treatments, which is designed to be quickly reviewed by clinician, who then prescribes medication based on his experience, knowledge and patient’s history. The system accounts for drug allergies into the treatment mapping process. Resulting recommendations highlight first-line and alternative options that respect these allergy constraints. 

Yes. The system accounts for drug allergies into the treatment mapping process. Resulting recommendations highlight first-line and alternative options that respect these allergy constraints. 

By aligning antibiotic suggestions with current evidence  and reference guidelines, TreatOnce™ helps to promote appropriate, targeted antimicrobial use to reduce unnecessary or suboptimal antibiotic prescribing. 

The application interface, reports, and other outputs can be customized including your organization’s name, logo, colors, and branding. 

Pricing is not specified on this page. For detailed information on licensing, implementation, and support costs, prospective customers are directed to contact Medix Biotechnologies sales or business development team at sales@medixbio.com. 

The page invites users to sign up to try a free TreatOnce™ demo. Interested users can follow the “Sign Up” link on the TreatOnce™ product page or reach out through Medix Biotechnologies’ contact channel.